News
Sanofi secures exclusive rights to develop plozasiran in Greater China, enhancing treatment options for hypertriglyceridemia ...
21h
Zacks Investment Research on MSNSarepta to Report Q2 Earnings: What's in Store for the Stock?We expect Sarepta Therapeutics SRPT to report second-quarter 2025 earnings on Aug. 6, after market close. The company’s ...
New to The Street Host Exclusive Investor Cocktail Event Featuring MUSQ ($MUSQ), The Music ETF, on September 3 at Hudson ...
Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results